Fred B. Craves, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 3,400 shares at $350.71 ($1.2M) on 2024-11-25, disclosed to the SEC on 2024-11-27.
Open-market sale of $1.2M MDGL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $350.08 | 2,200 | $770K | 64.7% |
| 2 | $350.71 | 1,200 | $421K | 35.3% |
| Total | $350.30 avg | 3,400 | $1.2M | 100% |
| Filing → |
| MDGL | SELL | 2024-05-16 | $9.3M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |
| MDGL | SELL | 2019-12-13 | $253.1M | — | Filing → |